Finance

Lists
Q3 2026 earnings • released • EPS beat +0.42% • Revenue miss -0.32%
See results
MET:NYSE
Metlife Inc
$99.75
-3.05%
(-3.14) 1D
$100.00
+0.25% (+0.25)
After hours
Closed: Nov 5, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MET...
Open
$104.50
High
$106.72
Low
$99.12
Mkt. cap
63.39B
Avg. vol.
3.23M
Volume
0.00
Dividend
2.38%
Quarterly dividend
$0.59
Ex-dividend date
Nov 3, 2026
P/E ratio
19.09
52-wk high
$106.72
52-wk low
$67.33
EPS
$5.23
Beta
0.79
Shares outstanding
635.48M
No. of employees
46K
Open
$104.50
High
$106.72
Low
$99.12
Mkt. cap
63.39B
Avg. vol.
3.23M
Volume
0.00
Dividend
2.38%
Quarterly dividend
$0.59
Ex-dividend date
Nov 3, 2026
P/E ratio
19.09
52-wk high
$106.72
52-wk low
$67.33
EPS
$5.23
Beta
0.79
Shares outstanding
635.48M
No. of employees
46K
News stories
From web sources and news partners
Profile
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company, better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. On January 6, 1915, MetLife completed the mutualization process, changing from a stock life insurance company owned by individuals to a mutual company operating without external shareholders and for the benefit of policyholders. After 85 years as a mutual company, MetLife demutualized into a publicly traded company with an initial public offering in 2000. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia's Pacific region, Europe, and the Middle East. MetLife serves 90 of the largest Fortune 500 companies. Wikipedia
About Metlife Inc
CEOMichel A. Khalaf
Employees46K
FoundedMar 24, 1868
HeadquartersNew York, New York, United States
SectorFinancials
IndustryInsurance
Websitemetlife.com
Analyst ratings
Based on 12 analysts giving stock ratings to MET in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for MET in the last 3 months.
Highest
Current $99.75
$131.00 (+31.33%)
Average
$112.64 (+12.92%)
Lowest
$108.00 (+8.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Newsome
Piper Sandler
Buy
Maintained
$110.00
+10.3%
11/05/2026
Wesley Carmichael
Wells Fargo
Buy
Maintained
$110.00
+10.3%
11/04/2026
Joshua Shanker
Bank of America Securities
Buy
Maintained
$131.00
+31.3%
11/05/2026
Alex Scott
Barclays
Buy
Maintained
$111.00
+11.3%
11/05/2026
Andrew Kligerman
TD Cowen
Buy
Maintained
$114.00
+14.3%
10/21/2026
Pablo Singzon
J.P. Morgan
Buy
Reiterated
$110.00
+10.3%
10/15/2026
Ryan Krueger
KBW
Buy
Maintained
$108.00
+8.3%
10/08/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
$109.00
+9.3%
10/07/2026
Michael Ward CFA
UBS
Buy
Maintained
$110.00
+10.3%
10/06/2026
Bob Huang
Morgan Stanley
Buy
Reiterated
$111.00
+11.3%
10/05/2026
Suneet Kamath
Jefferies
Buy
Maintained
$115.00
+15.3%
10/01/2026
Wilma Burdis
Raymond James
Hold
Maintained
-
-
09/29/2026
Elyse Greenspan
Wells Fargo
Buy
Maintained
$109.00
+9.3%
08/19/2026
Unknown Analyst
Raymond James
Hold
Maintained
-
-
06/30/2026
John Barnidge
Piper Sandler
Hold
Maintained
$90.00
-9.8%
06/24/2026
Jimmy Bhullar
J.P. Morgan
Buy
Reiterated
$96.00
-3.8%
05/12/2026
Thomas Gallagher
Evercore ISI
Hold
Maintained
$96.00
-3.8%
04/09/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$2.78 / $2.77
+0.42%beat
Revenue / Est. (USD)
19.91B / 19.97B
-0.32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
23.81B
19.07B
19.15B
20.52B
Cost of goods sold
19.28B
13.65B
14.54B
14.56B
Cost of revenue
19.28B
13.65B
14.54B
14.56B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
3.42B
3.53B
3.55B
2.99B
Total operating expenses
22.70B
17.18B
18.10B
17.55B
Operating income
1.11B
1.89B
1.06B
-
Other non operating income
267.00M
-120.00M
270.00M
320.00M
EBT including unusual items
1.12B
1.51B
1.04B
3.00B
EBT excluding unusual items
1.12B
1.51B
1.04B
3.00B
Income tax expense
301.00M
345.00M
256.00M
588.00M
Effective tax rate
26.95%
22.89%
24.73%
19.60%
Other operating expenses
3.42B
3.53B
3.55B
2.99B
Net income
809.00M
1.18B
736.00M
2.40B
Net profit margin
3.40%
6.21%
3.84%
11.68%
Earnings per share
2.49
2.42
2.43
2.78
Interest and investment income
-
-
-
-
Interest expense
-263.00M
-265.00M
-292.00M
-291.00M
Net interest expenses
-263.00M
-265.00M
-292.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.78B
1.92B
1.10B
3.01B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps